Literature DB >> 11748207

Production of prostaglandins and leukotrienes by pathogenic fungi.

Mairi C Noverr1, Galen B Toews, Gary B Huffnagle.   

Abstract

These studies demonstrate that pathogenic fungi (dermatophytic, subcutaneous, and systemic) have the ability to produce eicosanoids both from simple metabolites and from arachidonic acid. Host-derived eicosanoids have been previously demonstrated to enhance fungal colonization and atopic disease development. Thus, fungus-derived eicosanoids represent a potential class of novel virulence factors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11748207      PMCID: PMC127633          DOI: 10.1128/IAI.70.1.400-402.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Immunity to fungi: editorial overview.

Authors:  L Romani; S H Kaufmann
Journal:  Res Immunol       Date:  1998 May-Jun

2.  Regulation of human alveolar macrophage- and blood monocyte-derived interleukin-8 by prostaglandin E2 and dexamethasone.

Authors:  T J Standiford; S L Kunkel; M W Rolfe; H L Evanoff; R M Allen; R M Strieter
Journal:  Am J Respir Cell Mol Biol       Date:  1992-01       Impact factor: 6.914

Review 3.  Review of fungus-induced asthmatic reactions.

Authors:  H F Kauffman; J F Tomee; T S van der Werf; J G de Monchy; G K Koëter
Journal:  Am J Respir Crit Care Med       Date:  1995-06       Impact factor: 21.405

4.  Prostaglandin D2 as a mediator of allergic asthma.

Authors:  T Matsuoka; M Hirata; H Tanaka; Y Takahashi; T Murata; K Kabashima; Y Sugimoto; T Kobayashi; F Ushikubi; Y Aze; N Eguchi; Y Urade; N Yoshida; K Kimura; A Mizoguchi; Y Honda; H Nagai; S Narumiya
Journal:  Science       Date:  2000-03-17       Impact factor: 47.728

Review 5.  Respiratory fungal allergy.

Authors:  V P Kurup; H D Shen; B Banerjee
Journal:  Microbes Infect       Date:  2000-07       Impact factor: 2.700

6.  The diagnosis and incidence of allergic fungal sinusitis.

Authors:  J U Ponikau; D A Sherris; E B Kern; H A Homburger; E Frigas; T A Gaffey; G D Roberts
Journal:  Mayo Clin Proc       Date:  1999-09       Impact factor: 7.616

7.  Prostaglandin E2 biphasic control of lymphocyte proliferation: inhibition by picomolar concentrations.

Authors:  M G Sergeeva; M V Gonchar; A T Mevkh; S D Varfolomeyev
Journal:  FEBS Lett       Date:  1997-12-01       Impact factor: 4.124

8.  Leukotriene B4 induces interleukin 5 generation from human T lymphocytes.

Authors:  K A Yamaoka; J P Kolb
Journal:  Eur J Immunol       Date:  1993-10       Impact factor: 5.532

9.  Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression.

Authors:  S L Kunkel; M Spengler; M A May; R Spengler; J Larrick; D Remick
Journal:  J Biol Chem       Date:  1988-04-15       Impact factor: 5.157

10.  Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection.

Authors:  V Angeli; C Faveeuw; O Roye; J Fontaine; E Teissier; A Capron; I Wolowczuk; M Capron; F Trottein
Journal:  J Exp Med       Date:  2001-05-21       Impact factor: 14.307

View more
  52 in total

1.  Transient neutralization of tumor necrosis factor alpha can produce a chronic fungal infection in an immunocompetent host: potential role of immature dendritic cells.

Authors:  Amy C Herring; Nicole R Falkowski; Gwo-Hsiao Chen; Rod A McDonald; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13.

Authors:  Mairi C Noverr; Nicole R Falkowski; Rod A McDonald; Andrew N McKenzie; Gary B Huffnagle
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 3.  The mycobiota: interactions between commensal fungi and the host immune system.

Authors:  David M Underhill; Iliyan D Iliev
Journal:  Nat Rev Immunol       Date:  2014-06       Impact factor: 53.106

4.  Antifungal activity of some cyclooxygenase inhibitors on Candida albicans: PGE2-dependent mechanism.

Authors:  Andreza Urba de Quadros; Daniel Bini; Priscilla Aparecida Tartari Pereira; Estela Glória Moroni; Marta Chagas Monteiro
Journal:  Folia Microbiol (Praha)       Date:  2011-06-29       Impact factor: 2.099

5.  Response to Fungal Dysbiosis by Gut-Resident CX3CR1+ Mononuclear Phagocytes Aggravates Allergic Airway Disease.

Authors:  Xin Li; Irina Leonardi; Alexa Semon; Itai Doron; Iris H Gao; Gregory Garbès Putzel; Youngjun Kim; Hiroki Kabata; David Artis; William D Fiers; Amanda E Ramer-Tait; Iliyan D Iliev
Journal:  Cell Host Microbe       Date:  2018-11-29       Impact factor: 21.023

Review 6.  Production of cross-kingdom oxylipins by pathogenic fungi: An update on their role in development and pathogenicity.

Authors:  Gregory J Fischer; Nancy P Keller
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

7.  Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE₂.

Authors:  Yun-Gi Kim; Kankanam Gamage Sanath Udayanga; Naoya Totsuka; Jason B Weinberg; Gabriel Núñez; Akira Shibuya
Journal:  Cell Host Microbe       Date:  2014-01-15       Impact factor: 21.023

8.  Role of antibiotics and fungal microbiota in driving pulmonary allergic responses.

Authors:  Mairi C Noverr; Rachael M Noggle; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

9.  Leucine/valine residues direct oxygenation of linoleic acid by (10R)- and (8R)-dioxygenases: expression and site-directed mutagenesis oF (10R)-dioxygenase with epoxyalcohol synthase activity.

Authors:  Ulrike Garscha; Ernst H Oliw
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

Review 10.  Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes.

Authors:  Mairi C Noverr; John R Erb-Downward; Gary B Huffnagle
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.